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1. Introduction
The metabolome of a cell, tissue, organ, or organism is represented by its small molecular
metabolites (molecular weight less than 1000 Da), which are the end products of cellular
processes. Variation of the metabolome reflects the interaction of changes in upstream
molecules, such as genes and proteins with environmental factors. Metabolic profiling, which
is the high-throughput characterization of the metabolome, can be used to assess health status
and is a potential diagnostic tool for human diseases. Historically, the sweetness of urine was
used to diagnose diabetes. In late 1940s and early 1950s, Roger Williams and colleagues
introduced the concept of a “metabolic pattern” to explain the results from their paper
chromatography studies that distinguished saliva and urine components among individuals
[1]. However, this concept was not widely accepted until the 1960s, when gas chromatography
(GC) was successfully used for profiling a complex biological matrix. In the 1960s and 1970s,
GC and gas chromatography-mass spectrometry (GC-MS) were successfully used to diagnose
metabolic disorders, including maple syrup urine disease [2] and phenylketonuria [3]. In the
early 1970s, the term “metabolic profiles” was conceived by Hornings to describe the chro‐
matographic pattern associated with bio-fluid analysis [4].
With the improvement of the sensitivity for the instrument and statistical analysis tools, the
field of metabolomics (metabonomics) consequently developed at the end of last century and
has been widely used in the past decade. In addition to GC-MS, nuclear magnetic resonance
(NMR) and other chromatography coupled mass spectrometry, such as liquid chromatogra‐
phy-mass spectrometry (LC-MS) and capillary electrophoresis–mass spectrometry (CE-MS),
are widely used as analytical tools for metabolomics. Compared with other analytical tools,
GC-MS is one of the most efficient, sensitive, and reliable tools for metabolomics studies. GC-
MS produces reproducible molecular fragmentation patterns making it an integral tool for
metabolite identification. Although the application of GC is limited to volatile compounds
(before or after derivatization), a large portion of small molecular metabolites are within the
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range of GC separation. For their different metabolic windows among NMR, LC-MS, CE-MS,
and GC-MS, the combination of two or more analytical platforms has been used in many
metabolomics studies.
In this chapter we introduce GC-MS-based metabolomics. We will begin with the introduction
of GC-MS-based metabolomics procedures, and then describe each section of the procedures
in more detail. GC-MS-based metabolomics have been utilized in various areas (such as
biomedical research, plant research, and microbial research) as well as for different types of
samples. We will also provide some examples of using GC-MS-based metabolomics studies in
these described fields.
2. Overview of GC-MS-based metabolomics
Prior to GC-MS analysis, effective sample collection and processing methods are necessary to
optimize analyte yield and instrument performance. The collected samples can be liquid, solid,
or gas, and different sample pretreatment procedures can be used on different sample types.
For complex matrices and solid samples such as blood, tissue, and cell pellets, metabolite
extraction is necessary to diminish the matrix effect arising from the complex biological
materials. Unlike LC-MS and NMR-based metabolomics, compound derivatization is neces‐
sary to increase the volatility of metabolites containing polar functional groups, such as
carboxylic and amino groups. The volatile compounds (pre- or post-derivatization) are
subjected to GC-MS analysis and data collection. To understand the complex mass signals, a
data processing procedure should be performed to identify the true signals, assign the signals
into different compounds, and align these compounds from different samples. The aligned
data can then reveal the differential variables with different sample groups based on statistical
analysis. After peak annotation, the metabolic pathway associated with certain physiological
or pathological variations can be obtained. Therefore, the entire process is comprised of sample
collection, metabolites extraction, compound derivatization, instrument analysis, data
analysis, and metabolite annotation and pathway analysis (Figure 1).
3. Sample collection
Typical samples for GC-MS-based metabolomics can be bio-fluids, tissue, or cell samples. For
biomedical or clinical use, bio-fluids are widely used due to the non-invasive collection
procedures. Bio-fluids have also been considered to be good sources of diagnostic biomarkers.
The most widely used bio-fluids are serum/ plasma and urine. Saliva, tears, and sweat are also
used in metabolomics studies. Tissue samples can be obtained from animals, human beings,
or plants; and cell samples can be from mammals, plants, or microorganisms. Specific sample
collection procedures may impact reproducibility, sensitivity and yield of identified metabo‐
lites. Here, we will use blood sample collection and treatment as an example to show how the
procedure can impact the metabolomics results.
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3.1. Serum or plasma
For blood samples, both serum and plasma can be obtained using different biochemical
processes after collection. Serum samples are subjected to a clotting process, which mainly
removes fibrinogens, while plasma samples need an anticoagulant during the separation from
blood cells. Do these different processes cause variation in metabolites? Is serum or plasma
better for metabolomic studies? To answer these questions, previous studies were performed
using different analytical platforms. The results showed that there were only slight differences
between plasma and serum samples. Using NMR, Teahan et al. showed minor peak shifts
between serum and plasma (heparin used as the anticoagulant) samples, such as intensity
differences in the resonance dominated by lipid/ triglyceride peaks [5]. In an LC-MS-based
untargeted metabolomics study, differences between the serum and plasma (heparin used as
the anticoagulant) samples were found to be peptide/protein fragments and lysophophatidy‐
linositol. A lower concentration of lysophophatidylinositol in serum samples was due to
degradation in the blood clotting cascade [6]. In an LC-MS/MS-based targeted metabolomics
study [7], the authors compared 122 metabolites (focus on lipids and amino acids) between
serum and plasma (EDTA used as the anticoagulant) samples. That study found a high
correlation between serum and plasma concentrations in all of the targeted metabolites and a
Figure 1. The procedure for GC-MS-based metabolomics.
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slightly higher concentration of metabolites in serum samples. There was also better repro‐
ducibility with the plasma samples, but higher sensitivity with the serum samples.
In addition to NMR and LC-MS, GC-MS-based metabolomics has also been used to evaluate
the differences between serum and plasma samples. Dettmer et al. showed slightly higher
concentrations in most of the 26 quantified metabolites (19 amino acids, 6 organic acids, and
glucose), with the exception of pyruvate, malate, citrate, and glucose in serum samples
compared to plasma samples (EDTA used as the anticoagulant) [8]. Only lactate and citrate
had variation greater than 15%, which could be attributed to serum and plasma sample
preparation. The clotting time for serum preparation may result in a higher level of lactate in
the serum due to glycolysis occurring in the blood cells. The conjugation of cations (such as
Ca2+ and Mg2+) with EDTA (the anticoagulant) lowers the concentration of cations in the
plasma, which conjugate with citrate during the metabolite extraction process [8]. Slightly
higher metabolite concentrations in the serum samples were observed using different analyt‐
ical platforms, which may be due to lower protein levels in the serum samples as a result of
fibrinogen removal during the clotting procedure. Taken together, data from multiple
analytical platforms indicate that serum and plasma samples generate similar metabolomics
results.
3.2. Pre-analytical variations in serum and plasma samples
In both serum and plasma samples, metabolite variations can be derived during the sample
collection and preparation procedures. Therefore in order to acquire high quality samples for
metabolomics studies, a suitable protocol for sample collection is very important. In a NMR-
based metabolomics study, Teahan et al. analyzed metabolite variations under different
processing conditions, and found slight differences in serum samples processed with different
clotting times (up to 180 min) regardless of the temperature used (ice or room temperature) [5].
NMR spectrometry has also detected variations between samples caused by freeze-thaw
cycles, and therefore it is important to minimize the number of freeze-thaw cycles during
sample handling. Serum samples were found to be stable for 24 hours at 40C and 4 hours at
room temperature [9].
4. Metabolite extraction
Due to the complexity of metabolites with respect to their chemical structures and properties,
molecular weight, and concentrations, it is impossible to extract all metabolites using a single
extraction procedure. Different extraction procedures target different metabolites. Although
many extraction procedures are currently used, such as liquid-liquid extraction, solid-phase
extraction, and supercritical fluid extraction, liquid-liquid extraction is used more universally
for metabolomic studies. For polar metabolites, commonly used extraction solvents include
water, isopropanol, methanol, and acetonitrile, while for lipophilic metabolites, chloroform
and ethyl acetate are commonly used. To increase the extracted metabolites range, combina‐
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tions of extraction solvents, such as methanol/ chloroform or methanol/ chloroform/ water, are
used in many metabolite extraction procedures.
Methanol or methanol/chloroform combination is widely used for GC-MS-based metabolo‐
mics studies of blood samples (serum/ plasma). Using the combination of a D-optimal
experimental design and partial least squares projections to latent structures analysis, Jiye and
colleagues developed a methanol/water-based metabolites extraction procedure from plasma
[10]. In this study, the authors compared different solvents and their combinations including
water, methanol, ethanol, acetonitrile, acetone, and chloroform. Using methoxyamine and N-
Methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) derivatization, the authors resolved 501
peaks in a gas chromatography-Time-of-Flight mass spectrometry (GC-TOF-MS) analysis and
identified 80 metabolites from these peaks. Their study showed 100 µL of plasma mixed with
900 µL of methanol and water (8:1, v/v) provided optimal metabolites extraction results. Our
laboratory has found that the combination of methanol and chloroform (3:1, v/v) is better for
serum metabolite extraction than methanol alone [11]. Alternative ratios of methanol and
chloroform have also been used in other metabolomics studies. For example, Nishiumi and
colleagues used 250 µl of a solvent mixture (MeOH: H2O: CHCl3 = 2.5:1:1) for extracting 50 µl
of serum [12].
Liquid extraction is necessary for metabolomics studies with solid samples, such as tissue and
cell pellets. Tissue samples (from mammalian or plant) stored in liquid nitrogen need to be
ground to a fine powder prior to solvent extraction or homogenized in a solvent with blenders.
A combination of chloroform/methanol/water has been used extensively in metabolite
extraction from tissue. Denkert et al. used a combination of chloroform/methanol/water (2:5:2,
v/v/v) for colon tissue extraction [13]. Pan et al. developed a two-step metabolite extraction
procedure with a mixed solvent of chloroform/methanol/water (1:2:1, v/v/v) in the first step
and methanol in the second step for GC-TOFMS-based metabonomics study of liver tissue [14].
In addition, Gullberg et al. optimized an extraction protocol that yielded 66 metabolites from
Arabidopsis thaliana samples. The authors found that the optimal extraction mixture for plant
tissue was 200 µL of chloroform in a vibration mill followed by 800 µl of a methanol/water
mixture (75:25, v/v) to form a monophase [15].
The extraction procedures for collected cell pellets have been widely tested with different
solvents and various types of cells. Yeast is one of the most investigated species used for
targeted metabolites analysis. One commonly used intracellular procedure for metabolite
extraction is based on boiling ethanol, which was firstly described by Entian et al. in 1977 [16].
However, boiling ethanol may be harmful for some metabolites. Villas-Boas et al. tested 6
extraction conditions for yeast, including chloroform/methanol/buffer, boiling ethanol,
perchloric acid, potassium hydroxide, methanol/water, and pure methanol. Their results
indicated that pure methanol is the most suitable solvent and perchloric acid is the least suitable
for metabolite extraction [17]. After testing five extraction protocols, including methanol,
methanol/chloroform, perchloric acid, boiling ethanol and potassium hydroxide, Winder et al.
also found that cold methanol with repeated freeze/thaw cycles was most effective for
extracting intracellular metabolites from E. coli. [18]. For mammalian cells, methanol, metha‐
nol/water, and methanol/chloroform have been identified as suitable agents for metabolite
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extraction. Methanol/chloroform and boiling methanol with tricine buffer have been shown
to sufficiently extract metabolites involved in cellular energy metabolism from canine kidney
cells [19]. To increase the range of extracted metabolites, Sellick et al. reported a procedure
using two extractions in Chinese hamster ovary cells: the first with pure ethanol and the second
with water [20]. In addition, Dettmer et al. found that a methanol/water extraction yielded the
best results compared to pure methanol, pure acetone, acetone/water, methanol/chloroform/
water, methanol/isopropanol/water, or acid–base methanol in a colorectal cancer cell line
(SW480). They also found that direct scraping with methanol/water extraction markedly
improved the concentration of metabolites compared to trypsin/EDTA detachment [21].
5. Derivatization
GC-MS is designed to analyze volatile compounds that can pass through a gas chromatogra‐
phy column heated to approximately 300°C. Most metabolites have polar functional groups,
such as hydroxyl, amino, or carboxyl groups, and therefore are not volatile at the highest
temperature allowed by the GC system. Although some of the metabolites may pass through
the GC system, their peak shapes and/or recoveries are often unacceptable due to column
absorption. Therefore, protection of those polar functional groups from metabolites with
chemical derivatization is necessary.
To analyze as many metabolites as possible, wide range silylation is still the most popular
derivatization procedure prior to GC-MS metabolomics analysis. Silylation agents can react
with nearly all polar functional groups, including –COOH, –OH, –NH, and –SH. In general,
the silylation reaction and stability of the derivatized metabolites decrease in the following
order: –hydroxy > hydroxyl (phenol) > carboxylic acid > amine > amide; and primary >
secondary > tertiary for alcohols and amines. After silylation, metabolites are more volatile
and stable to high temperature. The most commonly used silylation agents for metabolomics
include N,O-bis-(trimethylsilyl)-trifluoroacetamide (BSTFA), MSTFA, and N-methyl-N-tert-
butyldimethylsilyltrifluoroacetamide (MTBSTFA) (Fig. 2). Typically, 1% trimethylchlorosi‐
lane (TMCS) is added as a catalyst for the reaction. Fiehn et al. recommended MSTFA instead
of BSTFA for metabolomics studies to avoid high volatility and volatile by-products, including
trifluoroacetamide, which causes some interference with early eluting peaks [22]. For keto (-
oxo) groups, direct derivatization with silylation will result in multiple products via enoliza‐
tion reactions, which can result in complicated chromatograms with quantification and
identification problems. Methoximation is always used to protect keto groups prior to
silylation in metabolomic studies, although it will generate two peaks with syn and anti
isoforms for the same keto-containing metabolite. For better separation between the syn and
anti isoforms, Fiehn et al. recommended alkoxyamines instead of hydroxylamines [22].
Since silylation agents are sensitive to moisture, it is important to dry the samples thoroughly
prior to the derivatization and prevent moisture exposure during the derivatization procedure.
The methoximation reaction can be completed in 1-2 hours with heat or overnight at room
temperature [10, 15]. Silylation reactions are usually finished in an hour at room temperature
or with heat at 60-70 0C.
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An alternative to TMS silylation is chloroformate derivatization, which has also been used in
metabolomic studies. Compare to silylation, the reaction with chloroformates can be conduct‐
ed in aqueous media, which is very convenient for bio-fluids such urine, serum, and saliva.
Reaction in the aqueous phase allows derivatization and analysis of certain volatile polar
metabolites, such as short chain fatty acids [23], which would evaporate from the sample
during the drying procedure prior to TMS derivatization. In addition, the reaction with
chloroformates is very quick; under ultra-sonication, the reaction can be finished in seconds
[24]. Chloroformate derivatization is widely used in quantitative measurements of amino
acids, organic acids, and amines prior to GC-MS analysis [24]. Qiu et al. successfully adapted
an ethyl chloroformate derivatization procedure for urine metabolomics analysis, which was
validated with 25 standards (amino acids, amines, and organic acids) and urine samples from
a precancerous rat model [25]. The authors used a two-step derivatization to increase the
metabolite range and intensity, and found the method to be efficient and robust. Tao et al.
subsequently optimized an ethyl chloroformate derivatization procedure for a serum metab‐
olomics study and successfully discriminated between uremic patients and normal subjects
[26]. However, only 50 metabolites were identified in that analysis, and thus this method has
not been widely used in serum metabolomic studies.
Chloroformate derivatization-based metabolomic analysis has also been used for microbial
cells. As reported by Smart et al., a methyl chloroformate (MCF) derivatization-based GC-MS
metabolomics analysis of microbial cells was able to profile the end products and/or inter‐
mediates from specific metabolic pathways, including glycolysis, the Kreb cycle, amino acid
metabolism, and fatty acid metabolism [27]. The authors described the advantages of MCF
derivatization as being an economical reagent with a fast derivatization procedure (1 min) and
less damage of the GC capillary column by the extraction solvent (chloroform).
Silylation and chloroformate derivatization are the two predominantly used procedures for
GC-MS-based metabolomic studies. Figure 2 illustrates examples of some of the derivatization
agents react with glycine.
6. Data analysis in GC-MS-based metabolomics
Data analysis for metabolomics study includes two key steps. The first step is to acquire a
readable dataset from mass spectrometry signals. The other step is to perform statistical
analysis, which allows comparisons of the same data generated from different analytical
platforms. However, different types of instruments generate different signal patterns. There‐
fore, in order to obtain better interpretation of the signals, specific computational programs
should be designed.
6.1. Signal interpretation for GC-MS-based metabolomics
The field of metabolomics studies the entire metabolome in a given biological sample.
Compared to conventional quantitative analytical studies, which target a limited number of
compounds, interpretation of mass signals from metabolomics is substantially more complex
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and difficult. This complexity lies in two main aspects: deconvolution of coeluting metabolites
and alignment of metabolites across multiple samples. An automated mass spectral deconvo‐
lution and identification system (AMDIS) developed by Stephen E. Stein is regarded as one of
the most powerful software programs for peak deconvolution [28]. This software is designed
to deconvolute coeluting compounds from a single sample and does not provide alignment
across samples. More recently, several software programs have been designed for GC-MS-
based metabolomic data analysis.
Hierarchical Multivariate Curve Resolution (H-MCR) is one of the pioneering software
programs that focuses on GC-MS-based metabolomics data [29]. Unlike conventional proce‐
dures, this software used a multiprocessing approach to process all interested samples
simultaneously. The generated results include the aligned peak information for all samples.
However, it will slow down the speed or even exceed computer’s capacity when simultane‐
ously processing a large size of samples. An improved procedure was subsequently developed
that allows the software to process a subset of representative training samples and generate
H-MCR parameters. Using the same parameters, the remaining samples can then be processed
very quickly [30].
Figure 2. Silylation and chloroformates derivatization with glycine.
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In 2008, Kopka and colleagues from the Max Planck Institute published a data processing
procedure for GC-MS-based metabolomics called TagFinder [31], which is based on the Java
programming language. In their process, the raw chromatography files with interchanged
format (such as the NetCDF format) or pre-processed peak lists are acceptable. Based on the
retention index or retention time, the fragment ions from different chromatograms are binned
to “mass tags”. After testing of the time groups, the selective mass tags can then be extracted.
This process supports both non-targeted fingerprinting and targeting profiling, and the
software is freely available for academic use from http://www-en.mpimp-golm.mpg.de/03-
research/researchGroups/01-dept1/Root_Metabolism/smp/TagFinder/index.html.
The Automated Data Analysis Pipeline (ADAP; available at http://www.du-lab.org) was
developed by Wenxin et al. in 2010. ADAP uses data generated by GC-TOFMS and contains
features such as peak detection, deconvolution, peak alignment, and library search [32]. This
software is written in standard C++ and R language. To increase the speed of the peak detection
and deconvolution steps, parallel computing via Message Passing Interface (MPI) was used.
The software was subsequently modified with improved algorithms mainly for peak decon‐
volution of coeluting metabolites, and substantial improvements in ADAP-GC 2.0 compared
to ADAP 1.0 have been reported [33].
In addition to software designed for GC-MS-based metabolomic studies, some software
originally developed for LC-MS data has also been used for GC-MS data analysis. XCMS is
one of the most popular software programs for MS-based metabolomic studies, and it was
originally developed based on LC-MS data [34]. This software was built using an R environ‐
ment. After data input, a filter and peak identification are performed. The identified peaks are
subjected to peak matching across samples. In this step, a group of metabolites are used as
standards for a nonlinear retention time correction. Missing values during the peak matching
step are filled in during the following step. Statistical analysis and peak visualization are the
last two steps. XCMS is freely available under an open-source license at http://
metlin.scripps.edu/download/. An online version includes all the same features and is
available at https://xcmsonline.scripps.edu [35]. Based on the results from XCMS, a meta-
comparison among different groups or complex subgroups can be subsequently performed
with metaXCMS (http://metlin.scripps.edu/metaxcms/) [36].
Other LC-MS-based software programs originally designed for LC-MS metabolomics data can
also be used for GC-MS-based metabolomic data analysis, including xMSanalyzer [37],
MZmine [38], and metAlign [39]. Vendors have also improved their software by adding
metabolomic tool kits. For example, ChromaTOF (LECO, St. Joseph, MI) now provides an
alignment function with its “Statistical Compare” section.
6.2. Statistical analysis
Metabolomic studies typically contain different groups with multiple samples in each group.
The aim of metabolomics is to identify metabolites (variables) that are highly correlated with
different conditions, such as gender, stimuli, and pathological status by making comparisons
among groups. Due to the complex dataset generated from the chromatography processing,
multivariate statistical analysis is typically used in addition to traditional univariate statistics.
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Multivariate analyses based on projection methods are popular in metabolomics studies [40,
41]. An unsupervised Principal Component Analysis (PCA) is usually applied to provide a
general overview of the acquired dataset and check for outliers. For more specific correlations
between the observations and variables, supervised pattern recognitions may be used, such
as Partial least-squares (PLS), Orthogonal-PLS (OPLS), PLS-discriminant analysis (PLS-DA),
and OPLS-DA. By setting a specific Y matrix, such as gender and pathological status, the
variables with high impact on the selected observations can be identified. Those metabolites
with high variable importance in the projection (VIP) value can then be selected as differenti‐
ating variables. In addition to projection-based methods, other pattern recognition technolo‐
gies, such as support vector machines (SVM) [42], hierarchical cluster analysis (HCA) [43], and
random forest (RF) [44] have also been used in metabolomic data processing.
To further characterize differentiating metabolites, univariate statistics, such as a Student’s t-
test, analysis of variance (ANOVA) test, and non-parametric Mann-Whitney V-tests, are used
to compare the selected differential variables from the multivariate statistics [45, 46]. For a
large number of distinct variables in the metabolomics data, the false discovery rate (FDR) is
used to correct p values from the univariate statistics [47].
7. Metabolite identification and interpretation
Accurate and reproducible compound identification is one of the most important reasons for
the popularity of GC-MS in metabolomics studies. However, because of the diversity in
chemical structures and concentrations, identification of metabolites remains a challenge. A
comparison with commercial libraries, such as the NIST and Wiley libraries, can tentatively
identify some of the metabolites. As discussed above, coeluting peaks are a major problem for
metabolite identification, and improvements in the separation conditions and advanced
deconvolution software (such as ADMIS and ChromaTOF) aid in the accuracy of compound
identification. In addition, due to the limited number of metabolite entries in current com‐
mercial libraries, even well separated metabolites cannot be identified. Many metabolomic
laboratories have developed their own metabolite libraries, which are also used to confirm the
identifications based on the retention time (or retention index). FiehnLib is one of the major
metabolomic databases and uses a fatty acid methyl ester retention index system. Using GC-
MS and GC-TOFMS (LECO, St. Joseph, MI), more than 1,000 primary metabolites, including
lipids, amino acids, fatty acids, amines, alcohols, sugars, amino-sugars, sugar alcohols, sugar
acids, organic phosphates, hydroxyl acids, aromatics, purines, and sterols have been entered
into this library [48].
In addition to biomarker discovery, metabolomics also aims to understand the metabolic
variations behind physiological or pathological changes. To obtain the entire picture of
metabolic changes, the detected metabolic variations are connected in the metabolic pathways.
In a pathway analysis, differential metabolites can be linked with each other as well as to the
corresponding genes and enzymes. One of the widely used integrated maps for metabolic
pathways, called the 22nd (2003) edition of the IUBMB-Sigma-Nicholson Metabolic Pathways
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Chart, is available online (http://www.sigmaaldrich.com/img/assets/4202/MetabolicPath‐
ways_6_17_04_.pdf). Other online sources for the metabolic pathway analysis include Kyoto
Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg), BioCyc (http://
www.biocyc.org/), Pathway Commons (PC, http://www.pathwaycommons.org/pc/), Small
Molecule Pathway Database (SMPDB, http://www.smpdb.ca/), Reactome (http://www.reac‐
tome.org/), The Arabidopsis Information Resource (TAIR, http://www.arabidopsis.org),
Expert Protein Analysis System (ExPASy, http://web.expasy.org/pathways/), the University
of Minnesota Biocatalysis/Biodegradation Database (UM-BBD, http://umbbd.msi.umn.edu/),
and others.
8. Applications of GC-MS-based metabolic profiling
Advanced GC-MS-based metabolic profiling techniques, which evolved with the development
of GC-MS instrumentation, were originally applied in biomedical research. However, in the
past several decades metabolic profiling has been widely used in plant, microorganism, and
environment research as well. In this section, we will introduce applications of GC-MS-based
metabolomics in these fields.
8.1. GC-MS-based metabolomics used in biomedical research
Variations in the metabolome are associated with both genetic alterations and environmental
interactions. Therefore, the field of metabolomics is an effective tool for biomedical research.
GC-MS-based metabolomics approaches are extensively used in biomarker discoveries and
biological understandings for human diseases, such as cancers, psychosis, and cardiovascular
diseases. Samples can be obtained from both patients and animal models.
Colorectal cancer (CRC) is among the most common types of cancer worldwide. GC-MS-based
metabolomics approaches have been used with various types of CRC samples, including urine,
serum, tissue, and stool. Qiu et al. used GC-MS analysis of urine from CRC patients and a 1,2-
dimethylhydrazine (DMH)-induced precancerous colon lesion rat model and their healthy
control counterparts [46]. Good separation was observed between CRC patients and healthy
controls, pre- and post-operative patients, and between precancerous colon lesion rats and
control rats. The authors observed significantly increased tryptophan metabolism as well as
disturbed tricarboxylic acid (TCA) cycle and gut microflora metabolism in both the CRC
patients and the rat model. In particular, recovery of tryptophan metabolism toward a healthy
state was observed in post-surgical samples. A similar study assessed sera metabolomics from
CRC patients and found perturbations in glycolysis, arginine and proline metabolism, fatty
acid metabolism, and oleamide metabolism [45]. Ong et al. detected enhancement of the purine
salvage pathway in CRC tumor tissues compared to adjacent normal epithelia [49]. Higher
concentrations of purines and pyrimidines in CRC tissues were also observed by Denkert et
al. based on GC-MS analysis [13]. They also observed higher levels of amino acids and lower
levels of intermediates of the TCA cycle and lipids in CRC tissues compared to adjacent normal
colon mucosa. In another study, GC-MS analysis was used for metabolic profiling of stool
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samples from 11 CRC patients and 10 healthy controls, and, higher concentrations of amino
acids and lower concentrations of fatty acids and ursodeoxycholic acid were observed in stool
samples from CRC patients compared to those from healthy adults[50].
Budczies et al. reported a GC-TOFMS-based metabolic profiling approach for comparing breast
cancer tissues to normal ones [51]. That study detected changes in several metabolic path‐
ways, including glycolysis, TCA cycle, nucleotide metabolism, and catabolism of amino acids.
They also found that the ratio of cytidine-5-monophosphate to pentadecanoic acid was able to
discriminate breast cancer tissues from controls with a sensitivity of 94.8% and a specificity of
93.9%. Using GC-MS analysis, Nam et al. detected four metabolic biomarkers (homovanillate,
4-hydroxyphenylacetate,  5-hydroxyindoleacetate,  and urea)  in  the  urine  of  breast  cancer
patients, which were validated with gene expression data from the NCBI GEO database [52].
GC-MS-based metabolomics approaches have also been used in several other cancer types,
including ovarian carcinoma [53], hepatocellular cancer [54], and osteosarcoma [55].
Several GC-MS-based metabolomics studies on diabetes have also been reported in recent
years. To identify metabolic signatures for a relatively new type of diabetes, fulminant type 1
diabetes (FT1DM), Lu et al. profiled the serum metabolome in FT1DM patients together with
healthy control subjects, type 2 diabetes, classic type 1 diabetes, and diabetic ketoacidosis
patients. Their study found that three metabolite markers (homocysteine, 5-oxoproline, and
glutamate) had diagnostic potential for diagnosing FT1DM [56]. GC-MS was also used to
evaluate metabolic variations of three drugs, including rosiglitazone, metformin, and repa‐
glinide, in type 2 diabetic patients using multivariate statistical analysis [57]. In another study,
two-dimensional GC-TOFMS-based metabolomics coupled with data from LC-MS analysis
implicated involvement of the gut microbiota in the development of type 1 diabetes [58].
In addition to cancer and diabetes, GC-MS-based metabolomics approaches have been used
in other diseases such as cardiovascular disease and psychosis. To identify metabolite
biomarkers for heart failure, Dunn et al. used a GC-MS technique to profile serum metabolites
from 52 patients with systolic heart failure and 57 controls [59]. Their observations revealed
two promising biomarkers for the failing heart: pseudouridine and 2-oxoglutarate. Yang et al.
profiled the serum metabolome in schizophrenia patients and healthy controls using GC-
TOFMS and found that fatty acid catabolism was up-regulated with elevated fatty acids and
beta-hydroxybutyrate levels in schizophrenia patients [60].
8.2. GC-MS-based metabolomics used in plant research
The plant cell metabolome has not been completely described due to the complexity of primary
and secondary metabolites in plants. New metabolites are continuously reported with the
development of advanced technologies. GC-MS is widely used in plant metabolomics studies
with its powerful separation and compound identification abilities. For example, Fiehn et al.
identified 15 relatively new metabolites in Arabidopsis extracts by calculating the elemental
compositions, and some were found to be completely novel in plant metabolism [22].
One focus in plant metabolomics is the elucidation of the correlation between genotypes and
metabolomic phenotypes. The effect of gene modification, identification of key genes and
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enzymes involved in existing metabolic pathways, or discovery of a new metabolic pathway
are widely investigated with metabolomics technology. One example of metabolomics in
genetically-modified plants was published in 2000 [61]. Fiehn et al. analyzed 326 distinct
compounds in Arabidopsis thaliana leaf extracts with GC-MS technology and successfully
distinguished four Arabidopsis genotypes (two homozygous ecotypes and a mutant of each
ecotype) from each other. In another study, Weckwerth et al. applied GC-TOFMS-based
metabolomics to a potato plant line with suppressed sucrose synthase isoform II expression
levels and found metabolic variations in carbohydrate and amino acid metabolism compared
to its parental background line [62].
A more specific link between metabolic regulation and gene or protein expression levels was
achieved with the combination of metabolomics and transcriptomic analysis. Using a GC–
TOFMS-based metabolomics technique, Albinsky et al. screened the metabolome of Arabidop‐
sis lines that overexpressed rice full-length (FL) cDNAs (rice FOX Arabidopsis lines) [63].
Combined with the transcriptome data, they found that Os-LBD37/ASL39 is a new transcrip‐
tional regulator for nitrogen metabolism in rice. Kusano et al. also revealed the importance of
cytosolic glutamine synthetase 1;1 (OsGS1) in the metabolic balance of rice plant growth [64].
In addition, Sulpice et al. attempted to link enzyme activities and metabolite levels to biomass
in Arabidopsis accessions [65]. Although the association was weak, it is a good example of a
metabolomics study using enzyme analysis.
Plant metabolism is largely influenced by genes and genetic modifications; however, the
environment can also impact changes in metabolism. Metabolomics is an effective tool for
investigating plant adaptive responses against environmental changes. One good example of
a link between environment changes and genetic modification was shown in a study using
metabolomics technology in Arabidopsis. Urano et al. analyzed metabolic variations of
Arabidopsis with a knock-out mutant of NCED3 gene wide type compared to the wide type
ones under dehydration stress using the combination of GC-MS and CE-MS [66]. Their results
showed the dependence of the accumulation of amino acids to abscisic acid production, and
the independence of the level of raffinose to abscisic acid production under dehydration stress.
Metabolomics technology has also been used to reveal how plants adapt to defend against
insects. Using GC-MS analysis, Kant et al. detected a significant increase in the emission of
volatile terpenoids in spider mite-infected tomato plants [67].
8.3. GC-MS-based metabolomics used in microbial research
Microorganisms are an essential component of both environmental and human intestinal
ecosystems, and they exhibit marked similarities with human beings in terms of metabolism.
Microbial metabolomic approaches are important tools for understanding the interactions
between human and environmental changes as well as cellular functions.
Escherichia coli represent a commonly found microorganism in the human gut and thus have
received extensive attention in previous metabolomics studies. In one time course response
study, E. coli were exposed to five different conditions (cold, heat, oxidative stress, lactose
diauxie, and stationary phase) [68]. The GC-MS-based metabolomic results showed similar
global impact on cell metabolism under different stresses, and metabolic signatures revealed
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a consistent decrease in the levels of metabolites related to glycolysis, the pentose phosphate
pathway, and the TCA cycle, which were in agreement with the transcriptomic data. In another
example, E. coli were used to investigate metabolic responses to different biofuel products,
including ethanol, butanol, and isobutanol [69]. The authors observed variations in amino
acids and osmoprotectants, including isoleucine, valine, glycine, glutamate, and trehalose in
E. coli cells exposed to biofuel stress. Stress-derived metabolic variations were also investigated
with other microorganisms including yeast. Using GC-MS analysis, Aggio et al. investigated
the metabolic changes in yeast cells exposed to different frequencies of sonic vibration and
silence and found that metabolic perturbations occurred at different sound frequencies [70].
GC-MS-based metabolomics technology can also be used to rapidly detect microorganisms
present in the environment or food. For example, Cevallos-Cevallos et al. developed a rapid
GC-MS-based procedure that could simultaneously detect 4 microorganisms in ground beef
or chicken: Escherichia coli O157:H7, Salmonella Typhimurium, Salmonella Muenchen, and
Salmonella Hartford [71]. In addition, a study by Sue et al. rapidly detected microbial contami‐
nation in fermentation processes using a metabolic footprint analysis approach [72].
9. Conclusions
With its powerful separation and identification ability, GC-MS is widely used in metabolomic
studies today. The technology is capable of analyzing non-polar metabolites directly and polar
metabolites through derivatization. Many GC-MS-based metabolomics protocols have been
developed and validated with various applications, and these applications have resulted in
new knowledge regarding metabolic networks as well as enhanced systemic understanding
of diseases, metabolic regulations, metabolic response to stresses, and cellular functions.
Promising diagnostic biomarkers have also been identified in biomedical research studies, and
novel microorganism detection procedures have been developed based on microbial metab‐
olomics. Although great achievements have been made with this technology, challenges still
remain. For instance, the processing of huge datasets generated from high-throughput
metabolomic studies and identification of those unknown peaks are two of the top challenges
for GC-MS-based metabolomics. With continuous development and application, GC-MS-
based metabolomics will be a powerful tool that benefits to our daily life.
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